Which closed-end funds own Boston Scientific Corp?
18 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $95.9M. Security type: common equity. Country: United States. CUSIP 101137107 · ISIN US1011371077 · ticker BSX.
Holdings are historical filings (report dates May 29, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 1.89% | $19.8M | 465,063 sh | $1.1B | 7.7% discount | Jun 30, 2026 |
| THW abrdn World Healthcare Fund | Healthcare | 1.67% | $11.5M | 270,298 sh | $689M | 4.3% discount | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 1.30% | $7.4M | 173,789 sh | $573M | 3.7% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 1.02% | $13.8M | 324,146 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.94% | $10.2M | 239,074 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| CII BlackRock Enhanced Large Cap Core Fund | U.S. Equity | 0.90% | $9.7M | 227,962 sh | $1.1B | 1.8% discount | Jun 30, 2026 |
| LGI Lazard Global Total Return & Income Fund | Multi-Asset | 0.60% | $1.6M | 36,685 sh | $262M | 8.0% discount | Jun 30, 2026 |
| JCE Nuveen Core Equity Alpha Fund | U.S. Equity | 0.55% | $1.7M | 38,870 sh | $302M | 5.9% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.39% | $881K | 20,650 sh | $228M | NAV unavailable | Jun 30, 2026 |
| NMAI Nuveen Multi-Asset Income Fund | Multi-Asset | 0.26% | $1.8M | 42,809 sh | $691M | NAV unavailable | Jun 30, 2026 |
| USA Liberty All Star Equity Fund | U.S. Equity | 0.24% | $4.8M | 111,736 sh | $2B | 12.8% discount | Jun 30, 2026 |
| ECAT BlackRock ESG Capital Allocation Term Trust | U.S. Equity | 0.15% | $2.5M | 58,348 sh | $1.7B | NAV unavailable | Jun 30, 2026 |
| CSQ Calamos Strategic Total Return Fund | Multi-Asset | 0.11% | $5.6M | 119,590 sh | $4.9B | 9.4% discount | Jul 31, 2026 |
| GAB Gabelli Equity Trust | U.S. Equity | 0.11% | $2.5M | 59,000 sh | $2.4B | 6.5% discount | Jun 30, 2026 |
| BCAT BlackRock Capital Allocation Term Trust | U.S. Equity | 0.09% | $1.5M | 36,069 sh | $1.7B | NAV unavailable | Jun 30, 2026 |
| ETW Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | Covered Call / Option Income | 0.07% | $854K | 20,000 sh | $1.2B | 11.2% discount | Jun 30, 2026 |
| GOF Guggenheim Strategic Opportunities Fund | Multi-Asset | 0.00% | $12.6K | 261 sh | $2.8B | 12.9% discount | May 29, 2026 |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust | U.S. Equity | -0.14% | $-361K | -7,722 sh | $259M | 15.9% discount | Jul 31, 2026 |
18 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: BOSTON SCIENTIFIC CORP.
Issuer-level search for “BSX” → · Compare two funds’ portfolios →